The “global arrangement,” as the legal team is calling it, comes on the heels of smaller settlements with other pharmaceuticals involved in the crisis. On August 26, a judge ordered Johnson & Johnson to pay $572 million to Oklahoma after he found that the company deceptively marketed opioids...
· Kate Goodwin Bladder cancer Pfizer’s Subcutaneous PD-1 Blocker Aces Phase III in Bladder Cancer, Carves Niche Versus Keytruda January 10, 2025 · 2 min read · Tristan Manalac Drug pricing Part D Drugs Almost Doubled in Cost Since Launch, Underscoring Importance of IRA: AARP ...
STAT’s findings flesh out some of the allegations aboutPurdue’s ties to Tuftsin the Massachusetts attorney general’slawsuitagainst the drug maker, its executives, and members of the Sackler family. With its funding, the suit contends, “Purdue got to control research on the treatment of pai...